The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Open accessAbstract
Glutamine is an essential nutrient that regulates energy production, redox homeostasis, and signaling in cancer cells. Despite the importance of glutamine in mitochondrial metabolism, the mitochondrial glutamine transporter has long been unknown. Here, we show that the SLC1A5 variant plays a critical role in cancer metabolic reprogramming by transporting glutamine into mitochondria. The SLC1A5 variant has an N-terminal targeting signal for mitochondrial localization. Hypoxia-induced gene expression of the SLC1A5 variant is mediated by HIF-2α. Overexpression of the SLC1A5 variant mediates glutamine-induced ATP production and glutathione synthesis and confers gemcitabine resistance to pancreatic cancer cells. SLC1A5 variant knockdown and overexpression alter cancer cell and tumor growth, supporting an oncogenic role. This work demonstrates that the SLC1A5 variant is a mitochondrial glutamine transporter for cancer metabolic reprogramming.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For mitochondrial glutaminolysis, cytosolic glutamine must be transported through the inner mitochondrial membrane via the SLC1A5 variant, a mitochondrial glutamine transporter16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“the mitochondrial glutamine transporter, encoded by a transcript variant of the SLC1A5 gene, which encodes a well-known plasma membrane glutamine transporter, was only recently discovered16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Although glutamate is the major downstream product of glutamine, glutamate supplementation during glutamine deprivation cannot rescue the impaired cell growth or mitochondrial respiration16,43–45, indicating that mitochondrial GLS-catalyzed cleavage of the gamma-nitrogen of glutamine is essential for glutaminolysis.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Hypoxic conditions promote the uptake of glutamine by increasing the levels of glutamine transporters such as SLC1A5, the SLC1A5 variant, and SLC38A216,65”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“and the mitochondrial glutamine transporter is strongly associated with glutaminolysis-induced NADPH generation16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Furthermore, redox modulation augmented by increased glutathione synthesis from glutamine was reported to be the mechanism of resistance to gemcitabine in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Impairing glutamine metabolism also induces sensitivity in gemcitabine-resistant pancreatic cancer cells16,84,85.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Indeed, experiments using uniformly labeled 13C-glutamine showed that glutathione was enriched with five 13C atoms in glutathione, suggesting that glutamine is the major source of glutathione16,57,60.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, hypoxia-induced expression of the SLC1A5 variant was shown to be mediated by HIF-2α and to lead to metabolic reprogramming toward glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Intriguingly, this study regarding elevated glutamine metabolism in cancer cells also showed that glutaminolysis could in turn reinforce metabolic reprogramming, thus implying that glutamine metabolism plays a crucial role in tumorigenesis and tumor progression16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Additionally, the level of the mitochondrial glutamine transporter controls the cellular ATP level stimulated by glutamine, suggesting that glutamine is an important energy source via mitochondrial glutaminolysis16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“in addition, the expression of the SLC1A5 variant affected the levels of metabolites derived from glucose metabolism, including lactate and ribulose-5-phosphate, the intermediate metabolites in the PPP16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, glutamine was shown to be a major fuel for mitochondrial oxygen consumption in pancreatic cancer cells”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Thus, as the SLC1A5 variant is the only currently known glutamine transporter in the mitochondrial inner membrane16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Given the clinicopathological significance of SLC1A5201 and the observation that the level of the SLC1A5 variant is negatively correlated with prognosis in several cancer types16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Conversely, suppression of the SLC1A5 variant, a mitochondrial glutamine transporter, is sufficient to inhibit tumor growth by impairing glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“HIF‐2α‐induced expression of the glutamine transporter solute carrier family 1, member 5 (SLC1A5) mediates glutamine‐induced ATP production and glutathione synthesis and renders pancreatic cancer resistant to gemcitabine.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [56]
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Importing Mitochondrial Proteins: Machineries and Mechanisms
Chacińska, A., Koehler, C. M., Milenkovic, D., Lithgow, T. J., & Pfanner, N. (2009) · Cell · doi:10.1016/j.cell.2009.08.005 · Cited by 1,528
Cited by
Sorted by citations
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,663
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Self-citationMitochondrial signal transduction
Picard, M. A., & Shirihai, O. S. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.008 · Cited by 688
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J., Choi, Y., & Park, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 605
The effect of HIF on metabolism and immunity
Taylor, C. T., & Scholz, C. C. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00587-8 · Cited by 517
Targeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 431
HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
Yao, X., Li, W., Fang, D., Xiao, C., Wu, X. W., Li, M., & Luo, Z. Y. (2021) · Advanced Science · doi:10.1002/advs.202100997 · Cited by 292
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Liu, S., Zhang, X., Wang, W., Li, X., Sun, X., Zhao, Y., Wang, Q., Li, Y., Hu, F., & Ren, H. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02165-x · Cited by 300
Ferroptosis: when metabolism meets cell death
Zheng, J., & Conrad, M. (2024) · Physiological Reviews · doi:10.1152/physrev.00031.2024 · Cited by 286
SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin, W., Wang, C., Liu, G., Bi, C., Wang, X., Zhou, Q., & Jin, H. (2020) · PubMed · Cited by 264
Ma, G., Zhang, Z., Li, P., Zhang, Z., Zeng, M., Liang, Z., Li, D., Wang, L., Chen, Y., Liang, Y., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00909-0 · Cited by 241
Exosomal circRNA: emerging insights into cancer progression and clinical application potential
Zhang, F., Jiang, J., Qian, H., Yan, Y., & Xu, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01452-2 · Cited by 221
Wang, Z., Liu, F., Fan, N., Zhou, C., Li, D., MacVicar, T., Dong, Q., Bruns, C. J., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589508 · Cited by 189
Metabolic heterogeneity in cancer
Demicco, M., Liu, X., Leithner, K., & Fendt, S. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00963-z · Cited by 186
Jin, H., Wang, S., Zaal, E. A., Wang, C., Wu, H.-Q., Bosma, A. R., Jochems, F., Isima, N., Jin, G., Lieftink, C., et al. (2020) · eLife · doi:10.7554/elife.56749 · Cited by 183
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 190
Nachef, M., Ali, A. K., Almutairi, S. M., & Lee, S.-H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624324 · Cited by 182
Amino acid metabolism, transport and signalling in the liver revisited
Paulusma, C. C., Lamers, W. H., Bröer, S., & van de Graaf, S. F. J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115074 · Cited by 185
Impact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B. R. G., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento‐Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 176
Glutathione and its precursors in cancer
Asantewaa, G., & Harris, I. S. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.03.001 · Cited by 160
Mitochondria in disease: changes in shapes and dynamics
Jenkins, B. C., Neikirk, K., Katti, P., Claypool, S. M., Kirabo, A., McReynolds, M. R., & Hinton, A. O., Jr. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.01.011 · Cited by 162
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Bao, X., Zhang, J., Huang, G., Yan, J., Xu, C., Dou, Z., Sun, C., & Zhang, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03505-1 · Cited by 152
Aspartic Acid in Health and Disease
Holeček, M. (2023) · Nutrients · doi:10.3390/nu15184023 · Cited by 151
Role of hypoxia in the tumor microenvironment and targeted therapy
Chen, G., Wu, K., Li, H., Xia, D., & He, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961637 · Cited by 148
Raho, S., Capobianco, L., Malivindi, R., Vozza, A., Piazzolla, C., Leonardis, F. D., Gorgoglione, R., Scarcia, P., Pezzuto, F., Agrimi, G., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00315-1 · Cited by 138
Lithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria
Ma, J., Tang, L., Tan, Y., Xiao, J., Wei, K., Zhang, X., Ma, Y., Tong, S., Chen, J., Zhou, N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01738-0 · Cited by 127
Páez-Franco, J. C., Torres-Ruiz, J. J., Sosa‐Hernández, V. A., Cervantes‐Díaz, R., Romero‐Ramírez, S., Pérez‐Fragoso, A., Meza-Sánchez, D. E., Germán-Acacio, J. M., Maravillas‐Montero, J. L., Mejía‐Domínguez, N. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85788-0 · Cited by 127
Nuclear metabolism and the regulation of the epigenome
Boon, R., da Silveira, G. G., & Mostoslavsky, R. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00285-4 · Cited by 129
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
Bosc, C., Saland, E., Bousard, A., Gadaud, N., Sabatier, M., Cognet, G., Farge, T., Boët, E., Gotanègre, M., Aroua, N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00264-y · Cited by 129
Okamatsu‐Ogura, Y., Kuroda, M., Tsutsumi, R., Tsubota, A., Saito, M., Kimura, K., & Sakaue, H. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154396 · Cited by 124
Jain, A., & Zoncu, R. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101481 · Cited by 122
Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How
Bröer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176156 · Cited by 116
Amino Acid Metabolism in Cancer Drug Resistance
Yoo, H.-C., & Han, J. M. (2022) · Cells · doi:10.3390/cells11010140 · Cited by 107
Self-citationAmmonia detoxification promotes CD8+ T cell memory development by urea and citrulline cycles
Tang, K., Zhang, H., Deng, J., Wang, D., Liu, S., Lu, S., Cui, Q., Chen, C., Liu, J., Yang, Z., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01365-1 · Cited by 105
Yan, Y., He, M., Zhao, L., Wu, H., Zhao, Y., Han, L., Wei, B., Ye, D., Lv, X., Wang, Y., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00963-8 · Cited by 101
Alleviating hypoxia to improve cancer immunotherapy
Fan, P., Zhang, N., Candi, E., Agostini, M., Piacentini, M., Bernassola, F., Bove, P., Alessandro, M., Giuseppe, N., Valentina, R., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02869-2 · Cited by 101
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Li, X., Peng, X., Li, Y., Wei, S., He, G., Liu, J., Li, X., Yang, S., Dai, L., Lin, W., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01449-x · Cited by 103
Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
Li, J., Zhang, D., Wang, S., Yu, P., Sun, J., Zhang, Y., Meng, X., Li, J., & Li, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.023 · Cited by 99
Comprehensive review of histone lactylation: Structure, function, and therapeutic targets
Xu, K., Zhang, K., Wang, Y., & Gu, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116331 · Cited by 102
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Nan, D., Yao, W., Huang, L., Liu, R., Chen, X., Xia, W., Sheng, H., Zhang, H., Liang, X., & Lü, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02018-6 · Cited by 98
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Halama, A., & Suhre, K. (2022) · Cancers · doi:10.3390/cancers14030553 · Cited by 93
Li, Y., Li, B., Xu, Y., Qian, L., Xu, T., Meng, G., Li, H., Wang, Y., Zhang, L., Jiang, X. W., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0042 · Cited by 90
Qi, X., Li, Q., Che, X., Wang, Q., & Wu, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.727778 · Cited by 86
Amino Acid Homeostasis in Mammalian Cells with a Focus on Amino Acid Transport
Bröer, S., & Gauthier-Coles, G. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab342 · Cited by 86
Metabolic reprogramming of clear cell renal cell carcinoma
Zhu, H., Wang, X., Lu, S., & Ou, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195500 · Cited by 83
Wang, X., Ding, B., Liu, W., Qi, L., Li, J., Zheng, X., Song, Y., Li, Q., Wu, J., Zhang, M., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03478 · Cited by 80
Gu, Z., Du, Y., Zhao, X., & Wang, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.029 · Cited by 81
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Gu, X., Mu, C., Zheng, R., Zhang, Z., Zhang, Q., & Liang, T. (2024) · Antioxidants · doi:10.3390/antiox13070778 · Cited by 79
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 78
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
Sniegowski, T., Korać, K., Bhutia, Y. D., & Ganapathy, V. (2021) · Pharmaceuticals · doi:10.3390/ph14030216 · Cited by 73
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex
Xie, L., Yuan, Y., Xu, S., Lü, S., Gu, J., Wang, Y., Wang, Y., Zhang, X., Chen, S., Li, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111498 · Cited by 72
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
Dvorak, V., Wiedmer, T., Inglés‐Prieto, Á., Altermatt, P., Batoulis, H., Bärenz, F., Bender, E., Digles, D., Dürrenberger, F., Heitman, L. H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.722889 · Cited by 72
Nutrient sensors and their crosstalk
Sung, Y., Yu, Y. C., & Han, J. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01006-z · Cited by 73
Self-citationLi, X., Zhu, H., Sun, W., Yang, X., Nie, Q. H., & Fang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02121-5 · Cited by 69
Zhang, Q., Wei, T., Jin, W. L., Yan, L., Shi, L., Zhu, S., Bai, Y., Zeng, Y., Yin, Z., Yang, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.024 · Cited by 68
Hushmandi, K., Einollahi, B., Saadat, S. H., Lee, E. H. C., Farani, M. R., Okina, E., Huh, Y. S., Nabavi, N., Salimimoghadam, S., & Kumar, A. P. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101952 · Cited by 72
Targeting metabolism to enhance immunotherapy within tumor microenvironment
Liang, X., Chen, X., Yan, Y., Cheng, A.-Y., Lin, J.-Y., Jiang, Y.-X., Chen, H., Jin, J., & Luan, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01304-w · Cited by 69
Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment
Frattaruolo, L., Brindisi, M., Curcio, R., Marra, F., Dolce, V., & Cappello, A. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176014 · Cited by 66
Linking Metabolic Reprogramming, Plasticity and Tumor Progression
Shuvalov, O., Daks, A., Fedorova, O., Petukhov, A., & Barlev, N. (2021) · Cancers · doi:10.3390/cancers13040762 · Cited by 63
Solute carriers: The gatekeepers of metabolism
Khan, A., Liu, Y., Gad, M., Kenny, T. C., & Birsoy, K. (2025) · Cell · doi:10.1016/j.cell.2025.01.015 · Cited by 63
Evan, T., Wang, V. M.-Y., & Behrens, A. (2022) · Oncogene · doi:10.1038/s41388-022-02448-x · Cited by 66
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer
Park, S. J., Yoo, H. C., Ahn, E., Luo, E., Kim, Y., Sung, Y., Yu, Y. C., Kim, K., Min, D. S., Lee, H. S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2045 · Cited by 63
Self-citationThe Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 59
Sequence Features of Mitochondrial Transporter Protein Families
Gyimesi, G., & Hediger, M. A. (2020) · Biomolecules · doi:10.3390/biom10121611 · Cited by 56
Wang, Q., Wu, M., Li, H., Rao, X., Ao, L., Wang, H., Yao, L., Wang, X., Hong, X., Wang, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106490 · Cited by 55
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
Hua, Q., Zhang, B., Xu, G., Wang, L., Wang, H., Lin, Z., Yu, D., Ren, J., Zhang, D., Zhao, L., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02023-w · Cited by 56
Targeting the glutamine-arginine-proline metabolism axis in cancer
Wang, D., Duan, J., Guo, Y., Chen, J., Chen, T.-Q., Wang, J., & Yu, S. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2367129 · Cited by 56
Supply and demand: Cellular nutrient uptake and exchange in cancer
Papalazarou, V., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.026 · Cited by 53
Chen, Z., Simon‐Molas, H., Cretenet, G., Valle‐Argos, B., Smith, L., Forconi, F., Schomakers, B. V., van Weeghel, M., Bryant, D. J., van Bruggen, J. A. C., et al. (2022) · Blood · doi:10.1182/blood.2021013990 · Cited by 55
Glutamine Metabolism in Cancer Stem Cells: A Complex Liaison in the Tumor Microenvironment
Pacifico, F., Leonardi, A., & Crescenzi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032337 · Cited by 53
PPIA dictates NRF2 stability to promote lung cancer progression
Lü, W., Cui, J., Wang, W., Hu, Q., Xue, Y., Liu, X., Gong, T., Lu, Y., Ma, H., Yang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48364-4 · Cited by 53
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
Fontana, F., & Limonta, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.024 · Cited by 53
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 52
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Deng, D., Patel, R. H., Chiang, C.-Y., & Hou, P. (2022) · Cells · doi:10.3390/cells11192952 · Cited by 53
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Liu, C., Li, C., & Liu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1108776 · Cited by 51
Bharadwaj, S., Singh, M. V., Kirtipal, N., & Kang, S. G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627842 · Cited by 50
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 52
Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy
Zhang, L., Wei, Y., Yuan, S., & Sun, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054954 · Cited by 49
Dinardo, C. D., Verma, D., Baran, N., Bhagat, T. D., Skwarska, A., Lodi, A., Saxena, K., Cai, T., Su, X., Guerra, V. A., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00811-3 · Cited by 48
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities
Nwosu, Z. C., Song, M. G., di Magliano, M. P., Lyssiotis, C. A., & Kim, S. E. (2023) · Oncogene · doi:10.1038/s41388-023-02593-x · Cited by 51
Emerging roles of the solute carrier family in pancreatic cancer
Wu, Z., Xu, J., Chen, L., Meng, Q., Hua, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.356 · Cited by 47
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Kim, M., Kim, H. S., Kang, H. W., Lee, D. E., Hong, W. C., Kim, J.-H., Kim, M., Cheong, J., Kim, H. J., & Park, J. S. (2023) · Cells · doi:10.3390/cells12202509 · Cited by 45
Self-citationMembrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45
20,000 picometers under the OMM: diving into the vastness of mitochondrial metabolite transport
Cunningham, C. N., & Rutter, J. P. (2020) · EMBO Reports · doi:10.15252/embr.202050071 · Cited by 44
Gluba-Brzózka, A., Rysz, J., Ławiński, J., & Franczyk, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063404 · Cited by 45
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Shuvalov, O. Y., Kirdeeva, Y., Daks, A. A., Fedorova, O., Parfenyev, S. E., Simon, H., & Barlev, N. A. (2023) · Antioxidants · doi:10.3390/antiox12112012 · Cited by 43
Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity
Yan, G., Han, Z., Kwon, Y., Jousma, J., Nukala, S. B., Prosser, B. L., Du, X., Pinho, S., Ong, S., Lee, W. H., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323683 · Cited by 43
Ma, G., Li, C., Zhang, Z., Liang, Y., Liang, Z., Chen, Y., Wang, L., Li, D., Zeng, M., Shan, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697894 · Cited by 45
Gorgoglione, R., Impedovo, V., Riley, C. L., Fratantonio, D., Tiziani, S., Palmieri, L., Dolce, V., & Fiermonte, G. (2022) · Cancers · doi:10.3390/cancers14010245 · Cited by 44
Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis
Ding, Z., Ericksen, R. E., Lee, Q. Y., & Han, W. (2021) · Amino Acids · doi:10.1007/s00726-021-02961-5 · Cited by 43
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42
Zhou, J., Sun, C., Dong, X., & Wang, H. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10070-0 · Cited by 42
COVID‐19 metabolism: Mechanisms and therapeutic targets
Wang, T., Cao, Y., Zhang, H., Wang, Z., Man, C. H., Yang, Y., Chen, L., Xu, S., Yan, X., Zheng, Q., et al. (2022) · MedComm · doi:10.1002/mco2.157 · Cited by 42
Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
Tang, Y., Zhang, Z., Chen, Y., Qin, S., Zhou, L., Gao, W., & Shen, Z. (2022) · Antioxidants · doi:10.3390/antiox11071324 · Cited by 47
Membrane transporters in cell physiology, cancer metabolism and drug response
Alam, S., Doherty, E., Ortega-Prieto, P., Arizanova, J., & Fets, L. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050404 · Cited by 44
Metadata
- Authors
- Yoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., Lee, C. W., Kang, J. S., Kim, Y.-H., Lee, J., Choi, J., Hwang, G.-S., Bang, S., & Han, J. M.
- Affiliations
- Yonsei University (KR)
- Korea Basic Science Institute (KR)
- National Cancer Center (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Han, Jung Min
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 267-283.e12
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2995576736
- Cited by
- 449
- References
- 54
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 87 · 2023: 67 · 2022: 67 · 2021: 55 · 2020: 29
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation of Korea
- Korea Basic Science Institute
- Ministry of Education (2018R1A6A1A03023718)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glutamine transport, tumor metabolic reprogramming, mitochondrial targeting signal, HIF-2α, hypoxia, glutathione synthesis, ATP production, gemcitabine resistance, pancreatic cancer, tumor growth
- MeSH terms
- Tumor Hypoxia, Endothelial PAS Domain-Containing Protein 1, Animals, Female, Glutamine, Humans, Mice, Inbred BALB C, Mitochondria, Neoplasms, Minor Histocompatibility Antigens, Amino Acid Transport System ASC, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
